Seema Kumar | CEO, Cure at 345 Park Avenue South

Seema Kumar | CEO, Cure at 345 Park Avenue South

• Seema is the CEO at Cure. 
• She has spent 20 years at Johnson & Johnson and has a background spanning NIH, Broad Institute, Whitehead Institute, and Hopkins.

Podcast: Play in new window | Download

Follow TBCY RSS

In an era defined by rapid technological advancements and pressing global health challenges, leaders like Seema Kumar stand at the forefront of innovation, wielding their expertise to forge transformative paths in healthcare. As CEO of Cure and with a distinguished career spanning Johnson & Johnson, and more, Seema Kumar embodies a commitment to integrating cutting-edge innovation with compassionate healthcare solutions. Join us as we delve into her insights on bridging innovation and healthcare to drive meaningful global impact.

[02:01] – About Seema Kumar

• Seema is the CEO at Cure. 
• She has spent 20 years at Johnson & Johnson and has a background spanning NIH, Broad Institute, Whitehead Institute, and Hopkins.

[09:50] – Reflecting on your tenure at Johnson & Johnson, known for its leadership in global health, how did you balance innovation and corporate responsibility, particularly during the challenges of the pandemic?

• At Johnson & Johnson, we prioritised patient needs, leveraging innovation across oncology, immunology, and infectious diseases. 
• The pandemic intensified our focus, leading to significant advancements in vaccine development and ensuring global accessibility.

[15:03] – As CEO of Cure, what exciting initiatives are you spearheading to improve the healthcare ecosystem?

• Cure aims to streamline healthcare innovation, bridging gaps between innovators, healthcare providers, and stakeholders. 
• Our goal is to create a cohesive ecosystem that enhances access and efficiency in healthcare delivery.

[32:11] – What are you most grateful and hopeful for?

• I am grateful for my involvement in the development of the Johnson & Johnson vaccine and the educational efforts around vaccines.
• I am hopeful due to several factors: advancements in technology, the emergence of the next generation of talented individuals, and meeting incredible people who are making significant contributions to society. 
• Despite distressing news in the media, I believe there is still hope and incredible talent working to make the world a better place. 

RESOURCES:

Learn more about Seema Kumar: LinkedIn

Enjoyed this podcast?

If you learned new insights about innovation and health care for global impact, subscribe and share them with friends! 

Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.

Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.  

You can find us at:

Website: www.tbcy.in 

Instagram: http://bit.ly/3HO7N06 

Facebook:http://bit.ly/3YzJOaD 

Twitter: http://bit.ly/3wMBOXK 

LinkedIn: https://www.linkedin.com/company/tbcy/ 

YouTube: http://bit.ly/3jmBqfq 

Chingari: https://chingari.io/tbcypodcast 

Moj:http://bit.ly/3wOrmPv 

Josh: http://bit.ly/3WWP0nB 

Thanks for listening! 

• Seema is the CEO at Cure. 
• She has spent 20 years at Johnson & Johnson and has a background spanning NIH, Broad Institute, Whitehead Institute, and Hopkins.